Association Between Clonal Hematopoiesis and Cardiometabolic Disease
Authors:
- Minna WooMWMinna Woo
- Calvin KeCKCalvin Ke
Open Access
- 16 June 2026
- journal article
- Published by Elsevier in JACC: Cardiooncology
- Vol. 8 (3) , 231-242
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Clonal Hematopoiesis and Cardiovascular Disease Risk After Cancer Therapy in Patients With Solid TumorsJAMA Oncology, 2026
- Impact of clonal hematopoiesis on cardiovascular outcomes in cancer patients of the UK BiobankESMO Open, 2025
- Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1JAMA Cardiology, 2024
- Clonal Hematopoiesis Risk Score and All-Cause and Cardiovascular Mortality in Older AdultsJAMA Network Open, 2024
- Clonal Hematopoiesis and Cardiovascular Disease in Patients With Multiple Myeloma Undergoing Hematopoietic Cell TransplantJAMA Cardiology, 2024
- Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular DiseaseJACC, 2023
- Association of clonal hematopoiesis mutations with clinical outcomes: A systematic review and meta‐analysisAmerican Journal of Hematology, 2022
- TET2-Loss-of-Function-Driven Clonal Hematopoiesis Exacerbates Experimental Insulin Resistance in Aging and ObesityCell Reports, 2020
- Current Scope and Challenges in Phenome-Wide Association StudiesCurrent Epidemiology Reports, 2017
- Meta-analysis of Observational Studies in EpidemiologyA Proposal for ReportingJAMA, 2000